These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6659661)

  • 21. [Comparative study of effect of Magnolia officinalis and M. officinalis var. biloba on gastrointestinal motility dysfunction].
    Peng B; He R; Yang B; Lu Y; Gao J; Li J
    Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(19):2624-7. PubMed ID: 21174779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What is assured in therapy of gastrointestinal diseases with drugs acting on motility?].
    Müller-Lissner S; Klauser A
    Internist (Berl); 1989 Dec; 30(12):797-804. PubMed ID: 2695489
    [No Abstract]   [Full Text] [Related]  

  • 23. New vistas on gastrointestinal motility: from physiology to therapy an international symposium in Rome.
    Currò D; Holzer P
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():1-2. PubMed ID: 18924439
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug modification of gastrointestinal motility].
    Lederer PC; Lux G; Domschke W
    Chirurg; 1988 Jan; 59(1):8-14. PubMed ID: 3349871
    [No Abstract]   [Full Text] [Related]  

  • 25. [Gastrointestinal motility disorders. Effective phytotherapy alternatives to MCP (metoclopramide)].
    MMW Fortschr Med; 2014 Nov; 156(19):80-1. PubMed ID: 25510031
    [No Abstract]   [Full Text] [Related]  

  • 26. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 27. [In which diseases is the use of motility-active measures indicated?].
    Wienbeck M; Barnert J
    Z Gastroenterol Verh; 1990 Apr; 25():138-40. PubMed ID: 1694351
    [No Abstract]   [Full Text] [Related]  

  • 28. [Motility-effective drugs for therapy of gastrointestinal functional disorders].
    Weihrauch TR; Kilbinger H
    Dtsch Med Wochenschr; 1982 Sep; 107(35):1323-8. PubMed ID: 6749465
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spasmolytic effect of plant carminatives. Animal experiment studies].
    Forster H
    ZFA (Stuttgart); 1983 Aug; 59(24):1327-33. PubMed ID: 6637000
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of decoctions, infusions and extracts of medicinal plants in diseases of the gastrointestinal tract].
    Galsanov ShB
    Med Sestra; 1988 Oct; 47(10):49-52. PubMed ID: 3231062
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new concept in the treatment of gastrointestinal diseases--Propulsin. Workshop, Beerse, Belgium, 16 June 1989].
    Internist (Berl); 1989 Sep; 30(9 Suppl):1-15. PubMed ID: 2635703
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dynamic radiotelemetric study of the stomach in relation to the use of several drugs].
    Samson EI
    Ter Arkh; 1967 Nov; 39(11):99-101. PubMed ID: 5629346
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical trial of the use of a drug combination in gastroenterology].
    Nizzo MC; Mavilio R; Lepore R
    Clin Ter; 1978 Mar; 84(5):491-500. PubMed ID: 348384
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of a new preparation in upper digestive processes].
    Maldonado Eloy-García J; Escalante Llamas A; Ariza Moscoso A; Moreno López JM; Pérez Olivares J
    Rev Esp Enferm Apar Dig; 1974 Apr; 43(1):89-108. PubMed ID: 4840627
    [No Abstract]   [Full Text] [Related]  

  • 36. [Central regulation of the motility of the digestive system with metoclopramide].
    Heynen U
    Z Allgemeinmed; 1969 Mar; 45(7):322-6. PubMed ID: 5778605
    [No Abstract]   [Full Text] [Related]  

  • 37. LC-MS-based plasma metabolomics study of the intervention effect of different polar parts of hawthorn on gastrointestinal motility disorder rats.
    Wang K; Luo L; Xu X; Chen X; He Q; Zou Z; Wang S; Liang S
    Biomed Chromatogr; 2021 Jun; 35(6):e5076. PubMed ID: 33476053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prokinetic drugs in gastroenterology].
    Galmiche JP; Bruley des Varannes S; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
    [No Abstract]   [Full Text] [Related]  

  • 39. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
    Schemann M; Michel K; Zeller F; Hohenester B; Rühl A
    Phytomedicine; 2006; 13 Suppl 5():90-9. PubMed ID: 16765572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse gastrointestinal dysmotility in a patient with rheumatoid arthritis.
    Ljubich P; Parkman HP; Fisher RS; Sorokin JJ; Conaway DC
    Am J Gastroenterol; 1993 Sep; 88(9):1443-5. PubMed ID: 8362846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.